Robeco Institutional Asset Management B.V. Cuts Holdings in Aflac Incorporated (NYSE:AFL)

Robeco Institutional Asset Management B.V. cut its position in Aflac Incorporated (NYSE:AFL - Free Report) by 0.9% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,310,921 shares of the financial services provider's stock after selling 11,640 shares during the quarter. Robeco Institutional Asset Management B.V. owned 0.24% of Aflac worth $145,761,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also modified their holdings of the company. Whipplewood Advisors LLC acquired a new stake in shares of Aflac in the fourth quarter valued at $26,000. Garde Capital Inc. acquired a new position in Aflac during the 1st quarter worth $36,000. BankPlus Trust Department acquired a new position in Aflac during the 4th quarter worth $34,000. Curio Wealth LLC acquired a new position in Aflac during the 4th quarter worth $36,000. Finally, Capital A Wealth Management LLC acquired a new position in Aflac during the 4th quarter worth $38,000. 67.44% of the stock is owned by institutional investors and hedge funds.

Aflac Stock Performance

Shares of Aflac stock traded up $1.21 on Friday, hitting $105.12. The stock had a trading volume of 11,667,977 shares, compared to its average volume of 2,152,036. Aflac Incorporated has a 52-week low of $88.00 and a 52-week high of $115.50. The company has a current ratio of 0.09, a quick ratio of 0.09 and a debt-to-equity ratio of 0.29. The stock has a market cap of $56.83 billion, a price-to-earnings ratio of 16.43, a P/E/G ratio of 3.22 and a beta of 0.82. The company's 50 day moving average price is $104.60 and its 200 day moving average price is $105.19.

Aflac (NYSE:AFL - Get Free Report) last posted its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share for the quarter, missing the consensus estimate of $1.67 by ($0.01). Aflac had a net margin of 21.27% and a return on equity of 15.55%. The firm had revenue of $3.40 billion during the quarter, compared to analysts' expectations of $4.53 billion. During the same period in the previous year, the firm posted $1.66 earnings per share. The firm's revenue for the quarter was down 37.5% on a year-over-year basis. On average, research analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current year.

Aflac Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 2nd. Shareholders of record on Wednesday, May 21st were paid a dividend of $0.58 per share. This represents a $2.32 annualized dividend and a yield of 2.21%. The ex-dividend date was Wednesday, May 21st. Aflac's dividend payout ratio is presently 36.25%.

Analysts Set New Price Targets

Several research analysts recently commented on AFL shares. Piper Sandler boosted their target price on Aflac from $118.00 to $124.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 2nd. UBS Group boosted their target price on Aflac from $109.00 to $114.00 and gave the stock a "neutral" rating in a research note on Wednesday, April 2nd. Barclays boosted their target price on Aflac from $95.00 to $96.00 and gave the stock an "underweight" rating in a research note on Thursday, May 1st. Wall Street Zen cut Aflac from a "hold" rating to a "sell" rating in a research note on Monday, May 5th. Finally, Morgan Stanley boosted their target price on Aflac from $100.00 to $105.00 and gave the stock an "equal weight" rating in a research note on Monday, May 19th. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, Aflac presently has a consensus rating of "Hold" and a consensus price target of $104.93.

Insider Buying and Selling at Aflac

In other Aflac news, Director Masatoshi Koide sold 37,000 shares of the company's stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $105.59, for a total transaction of $3,906,830.00. Following the completion of the sale, the director now directly owns 70,992 shares of the company's stock, valued at $7,496,045.28. This represents a 34.26% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Arthur Reginald Collins sold 2,750 shares of the company's stock in a transaction that occurred on Thursday, May 15th. The shares were sold at an average price of $105.70, for a total value of $290,675.00. Following the sale, the director now directly owns 6,728 shares of the company's stock, valued at approximately $711,149.60. This represents a 29.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 40,750 shares of company stock valued at $4,304,295 in the last ninety days. Insiders own 0.90% of the company's stock.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.